Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, and Tuberculosis Research and Epidemiology.
Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update
Subclinical tuberculosis linkage to care and completion of treatment following community-based screening in rural South Africa
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Omicron infection enhances Delta antibody immunity in vaccinated persons
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa
A position statement and practical guide to the use of particulate filtering facepiece (N95, FFP2, or equivalent) respirators for South African health care workers exposed to respiratory pathogens including M. tuberculosis and SARS-CoV-2
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen